Expanded Access for CC-10004

Amgen

Status

Conditions: Bechet's Disease

Treatments: Drug: CC-10004

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT03740516

CC-10004

Details and patient eligibility

About

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-10004.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria